No, this is not true. Vaccines undergo rigorous safety testing and are continuously monitored for adverse events.

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

The FDA also gave full approval to the Novavax COVID vaccine (Nuvaxovid) using this approach, approving it for those ages 65 ...

In recent interviews, Health and Human Services Secretary Robert F. Kennedy Jr. has minimized the risk COVID-19 poses to kids ...

FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...

Recommendations for the use of chikungunya vaccine were recently discussed at a meeting of the Advisory Committee on Immunization Practices.

On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of ...

For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.

In a notable development, the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have jointly issued an advisory urging American travellers aged 60 and above ...